4.3 Article

To Eat or Not to Eat-International Experiences With Eating During Hemodialysis Treatment

Journal

JOURNAL OF RENAL NUTRITION
Volume 24, Issue 6, Pages 349-352

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.jrn.2014.08.003

Keywords

-

Funding

  1. American Heart Association Predoctoral Fellowship
  2. National Institutes of Health [R21-DK078012, R01-DK084016]

Ask authors/readers for more resources

Providing food or nutrition supplements during hemodialysis (HD) may be associated with improved nutritional status and reduced mortality however despite these potential benefits eating practices vary across countries regions and clinics. Understanding present clinic practices and clinician experiences with eating during HD may help outline best practices in this controversial area. Therefore the objective of this study was to examine clinical practices and experiences related to eating during HD treatment. We surveyed clinicians about their clinic practices during the 2014 International Society of Renal Nutrition and Metabolism Conference. We received 73 responses from six continents. Respondents were primarily dietitians (71%) working at units housed in a hospital (63%). Sixty-one clinics (85%) allowed patients to eat during treatment with 47 of these patients (65%) actively encouraging eating. Fifty-three clinics (73%) provided food during HD. None of the nine clinics from North America however provided food during treatment. The majority (47 clinics 64%) provided supplements during treatment. Clinics in the hospital setting were more likely to provide food during treatment whereas outpatient clinics were less likely to provide nutrition supplements (P <= 0.05 for both). We also asked clinicians about their experience with six commonly cited reasons to restrict eating during treatment using a four-point scale. Clinicians responded they observed the following conditions rarely'' or never'': choking (98%) reduced Kt/V (98%) infection control issues (96%) spills or pests (83%) gastrointestinal issues (71%) and hypotension (62%). Our results indicate that while eating is common during treatment in some areas disparities may exist in global practices and most of the proposed negative sequelae of eating during HD are not frequently observed in clinical practice. Whether these disparities in practice can explain global differences in albumin warrants further research to help inform decisions regarding eating during HD. (C) 2014 by the National Kidney Foundation Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available